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Introduction 
 
Oral cancers are the sixth most common type of 
cancer among males and the twelfth most com-
mon type of cancer among females in the US. 
The most prevalent type of pre-cancerous ulcer 
in the oral cavity is leukoplakia, constituting 
about 85% of all oral lesions with an estimated 
global prevalence of 2.60% (1, 2). 
Based on the definition by the World Health Or-
ganization (WHO), leukoplakia is considered a 
white plaque or patch which does not resemble 
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any other ulcer pathologically or clinically. All 
leukoplakia lesions do not necessarily transform 
to malignancies and some show signs of com-
plete withdrawal and even complete cure, 
however, the lesion itself is considered as poten-
tially malignant (3, 4). Retrospective studies have 
documented different results regarding the rate 
of malignant transformation in leukoplakia le-
sions ranging from 0.13% to 36.4% (2, 5). 
Multiple factors have been shown to play a role 
in the malignant transformation of a leukoplakia 
lesion including patients' habits, genetic factors, 
existence of dysplasia and/or candidiasis infec-
tions, and age (6-8). The etiology and the occur-
rence of dysplastic change in leukoplakia are still 
not completely understood, furthermore cases of 
malignant transformation of hyperkeratosis leu-
koplakia without dysplastic change have been 
reported (9). 
Studies have shown different and in some cases, 
contradicting results regarding the risk factors 
that contribute to the malignant transformation 
of these lesions based on geographical region, 
cultural and lifestyle differences, which include a 
wide range of environmental factors and dietary 
habits (5, 10).  
In order to understand region-specific risk fac-
tors for malignant change in leukoplakia lesions, 
in this study we evaluated the factors that affect 
malignant transformation in a sample of the Ira-
nian population diagnosed with leukoplakia. 
 
Materials and Methods 
 
Study settings and protocol 
This study was conducted in Namazi and Khalili 
hospitals (Shiraz, Iran), which are two of the larg-
est referral centers in southern Iran.  
The study protocol was approved by the Institu-
tional Review Board of Shiraz University of Med-
ical Sciences. Guidelines of the Declaration of 
Helsinki were followed in all stages of the study.  
In this retrospective study, the records of all pa-
tients that referred for biopsy with a clinical diag-
nosis of leukoplakia during a 20-year period from 
Jan 1989 to Dec 2009, were considered for inclu-
sion in the study. Overall, 613 patients were in-
itially considered for inclusion as the study popu-
lation. Patients' secrecy of data was maintained 
throughout the study and no personal informa-
tion was disclosed regarding any of the patients. 
Patients that developed malignant changes in 
their leukoplakia lesions were considered as 
group 2 and those who did not develop any ma-
lignant change were considered as the benign 
group or group 1. Any patient that had missing 
data, had any other type of leukoplakia (other 
than oral) or had any other systemic or infectious 
disease was excluded from the study. 
Patients' records were reviewed and information 
regarding age, sex, site of lesion, clinical mor-
phology and smoking were registered and eva-
luated.  
Our patient information sheet was made of two 
different parts. The first part included demo-
graphic information that was obtained from the 
records and the second part included information 
on personal habits like smoking. For obtaining 
information regarding personal habits, we con-
tacted and visited the patients and asked them 
about their history of smoking and their amount 
of tobacco use. 
 
Measurements 
The site of lesion was classified into one of the 
following locations: gingiva of the upper jaw, 
gingiva of the lower jaw, mucosa of the buccal 
area, tongue, lips and the base of the mouth. 
Regarding clinical morphology, we classified the 
lesions into four categories: type 1 as flat and 
white patches or plaques without red compo-
nents, type 2 as flat and white patch or plaques 
with red components (erythroleukoplakia), type 3 
as red patch or plaques (erythroplakia) and type 4 
as raised or elevated white plaques. 
Patients were classified as having malignant le-
sions according to their biopsy results. 
For better evaluation of patients based on their 
age, we classified them into 8 age groups of <19, 
20-29, 30-39, 40-49, 50-59, 60-69, 70-79 and 80-
89 yr old. In another classification, patients were 
also classified as above 50 yr old and bellow 50 yr 
old. 
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Statistical analysis 
The study population size was defined using a 
pilot study and considering a power of 80% and 
α of 5%, accordingly an estimated 210 people 
were needed in each group. Data were analyzed 
using the SPSS for Windows, ver. 18 (SPSS Inc., 
Chicago, IL, USA). For comparison of quantita-
tive data between two groups, the independent t-
test was used and for comparison of qualitative 
data, the chi-square test was used. We used a un-
ivariate analysis to show risk factors for develop-
ing malignant change, reporting its odds ratio 
(OR) and 95% confidence interval (CI). We used 
a multivariate analysis using a logistic regression 
model to evaluate the simultaneous effect of dif-
ferent factors for the development of malignant 
changes. A two-tailed P-value of less than 0.05 
was considered as statistically significant. 
 
Results 
 
After reviewing for missing data, 522 cases en-
tered the study. Among these 522 cases, 210 were 
males. Overall, 213 patients showed signs of ma-
lignant transformation (group 2). Patients young-
er than 50 yr old mostly had benign lesions 
(78%), however, patients over 50 yr old mostly 
had lesions that developed malignant change 
(50.2%) (P<0.001). 
 The two groups showed a significant difference 
regarding their site of lesion (P<0.001). Majority 
of the lesions located on the tongue (63%) devel-
oped malignant change. This was the same for 
lesions located on the base of the mouth (54%). 
Erythroplakia lesions were mostly benign 
(93.3%), while flat and white patches or plaques 
without red components, erythroleukoplakia and 
raised or elevated white plaques mostly under-
went malignant changes (71%, 71%, and 56.7%, 
respectively) (P<0.001).  
Table 1: Patients' baseline and leukoplakia related characteristics in the two groups* 
 
Variables Group 1 (n=309) Group 2 (n=213)   
Sex Frequency – no. (%) Frequency – no. (%) Total P-value 
Male 141 (67.1) 69 (32.9) 210  
Female 168 (53.8) 144 (46.2) 312 0.002 
Age     
< 50 135 (78) 38 (22) 173  
> 50 174 (49.8) 175 (50.2) 349 <0.001 
Site of lesion     
Upper gingiva 38 (86) 6 (14) 44  
Lower gingiva 36 (78) 10 (22) 46  
Buccal 96 (67.6) 46 (32.4) 142 <0.001 
Tongue 65 (36.1) 115 (63.9) 180  
Lips 48 (89) 6 (11) 54  
Base of mouth 26 (46) 30 (54) 56  
Clinical morphology†     
1 24 (29) 58 (71) 82  
2 23 (29) 56 (71) 79 <0.001 
3 197 (93.3) 14 (6.7) 211  
4 65 (43.3) 85 (56.7) 150  
Smoking     
Yes 228 (74.5) 78 (25.5) 306 <0.001 
no 81 (37.5) 135 (62.5) 216  
*Group 1 represents patients with leukoplakia without malignant transformation and group 2 represents those with malignant 
transformation. Some of the numbers have been rounded for better evaluation. 
†Clinical morphology was considered as type 1: flat and white patches or plaques without red components; type 2: flat and white 
patch or plaques with red components (erythroleukoplakia); type 3: red patch or plaques; type 4: raised or elevated white plaques. 
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Most smokers had benign lesions (74.5%), while 
most non-smokers developed malignant lesions 
(62.5%) (Table 1). 
We compared males and females in the two 
groups based on different variables. Our results 
showed that in group 2, males and females had a 
significant difference in their distribution of age 
groups (P<0.001). In group 1, most of the pa-
tients (both male and females) were between the 
ages of 50-59 yr old. In group 2, females were 
mostly between 60-69 yr old, while male patients 
were between 50-59 yr old. In females, majority 
of malignant transformations were related to 
those lesions located on the tongue, while in 
males both the tongue and the buccal area were 
common areas for malignant transformation. The 
difference between males and females was signif-
icant regarding the location of leukoplakia 
(P<0.001). Although for benign lesions males 
and females displayed significant differences in 
clinical morphology of leukoplakia (P<0.001), in 
group 2, there was no difference between the two 
sexes (P=0.4). Female patients with malignant 
changes were mostly non-smokers (76.4%), while 
males in the group with malignant changes were 
mostly smokers (63.8% in non-smokers) 
(P<0.001) (Table 2). 
 
Table 2: Comparison of variables between males and females among the two group* 
 
Variables Group 1 (n=309)  Group 2 (n=213)  
  Frequency –no. (%) P-value Frequency –no. (%) P-value 
 Male (n=141) Female (n=168)  Male (n=69) Female (n=144)  
Age†       
< 19 2 (1.4) 0  0 0  
20 - 29 20 (14.1) 0  4 (5.7) 0  
30 - 39 19 (13.4) 11 (6.5)  5 (7.2) 4 (2.7)  
40 - 49 32 (22.6) 51 (30.3) 0.125 9 (13) 16 (11.1) <0.001 
50 - 59 48 (34) 57 (33.9)  32 (46.3) 37 (25.6)  
60 - 69 12 (8.5) 24 (14.2)  11 (15.9) 62 (43)  
70 - 79 7 (4.9) 24 (14.2)  7 (10.1) 22 (15.2)  
80 - 89 1 (0.7) 1 (0.5)  1 (1.4) 3 (2)  
       
< 50 73 (51.8) 62 (36.9)  18 (26.1) 20 (13.9)  
> 50 68 (48.2) 106 (63.1) 0.009 51 (73.9) 124 (86.1) 0.03 
Site of leukoplakia       
Upper gingiva 7 (5) 31 (18.5)  2 (2.9) 4 (2.8)  
Lower gingiva 9 (6.4) 27 (16.1)  4 (5.8) 6 (4.2)  
Buccal 27 (19.1) 69 (41.1)  23 (33.3) 23 (16)  
Tongue 54 (38.2) 11 (5.5) 0.125 27 (39.1) 88 (61.1) <0.001 
Lips 34 (24.1) 14 (8.3)  4 (5.8) 2 (1.4)  
Base of mouth 10 (7.2) 16 (9.5)  9 (13) 21 (14.6)  
Clinical morphology‡       
1 13 (9.2) 11 (6.5)  15 (21.7) 43 (29.9)  
2 21 (14.9) 2 (1.2)  21 (30.4) 35 (24.3)  
3 85 (60.3) 112 (66.7) <0.001 21.4 (4.3) 11 (7.6) 0.4 
4 22 (15.6) 43 (25.6)  30 (43.5) 55 (38.2)  
Smoking       
Yes 119 (84.4) 109 (64.9) <0.001 44 (63.8) 34 (23.6) <0.001 
no 22 (15.6) 59 (35.1)  25 (36.2) 110 (76.4)  
 
In our univariate analysis, male patients had a 
lower chance for developing malignant transfor-
mation (OR: 0.57; 95% Cl = 0.397-0.822). This 
was the same with smoking (OR: 0.205; 95% Cl: 
0.141-0.299). Age over 50 yr old was a risk factor 
for malignant change (OR: 3.57; 95% Cl = 2.35 - 
5.42) (Table 3). 
In our multivariate regression model, the effects 
of sex and age on malignant changes were abro-
gated. Smoking (OR: 0.317; 95% CI = 0.16–
0.626) and morphological presentation as eryt-
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hroplakia (OR: 0.025; 95% CI = 0.005-0.131) had 
low chances for developing malignant changes, 
while site of lesion on the tongue (OR: 774; 95% 
CI = 60-9838) and morphological presentation as 
erythroleukoplakia (OR: 6.26; 95% CI = 3.16-
12.38) were a risk factor for developing malignant 
changes (Table 4). 
 
Table 3: Odds ratio of different variables regarding malignant transformation 
 
Variables  Odds ratio 95% Confidence interval 
Sex    
Male 0.57 0.397 - 0.822 
Age – yr   
> 50 3.57 2.35 - 5.42 
Smoking   
Yes 0.205 0.141 - 0.299 
 
Table 4: Logistic regression for evaluating risk factors for malignant transformation 
 
Variables Odds ratio 95% Confidence interval 
Sex    
Male 1.08 0.555 - 2.128 
Age – yr   
> 50 1.8 0.877 - 3.69 
Smoking   
Yes 0.317 0.16 - 0.626 
Clinical morphology*   
Type 2 6.26 3.164 - 12.38 
Type 3 0.025 0.005 - 0.131 
Type 4 0.983 0.359 - 2.69 
Site of lesion†   
Tongue 774.556 60.94 - 9838.64 
Lower gingiva 0.513 0.115 - 2.27 
Buccal 0.626 0.117 - 2.21 
Lips 0.293 0.058 - 1.47 
Base of mouth 0.533 0.142 - 2.004 
*Type 1 clinical leukoplakia or flat, white patches or plaques without red components were considered as the base for compari-
son in the regression model.  
Type 2: flat and white patch or plaques with red components (erythroleukoplakia); type 3: red patch or plaques; type 4: raised or 
elevated white plaques. 
†For the site of leukoplakia, the upper gingiva was considered as the base for comparison in the regression model. 
 
Discussion 
 
The goal of our study was to evaluate regional 
factors that contribute to malignant changes in 
leukoplakia lesions in the Iranian population. We 
found that females and those over 50 yr old had 
more leukoplakia with malignant transformation. 
The most common site for malignant changes 
was on the tongue. In our multivariate analysis, 
erythroleukoplakia and location of a leukoplakia 
lesion on the tongue were risk factors for malig-
nant change, while erythroplakia lesions and leu-
koplakia associated with smoking were unlikely to 
develop malignant changes. 
In a cohort study from Amsterdam including 144 
patients (11), who had a definitive diagnosis of 
leukoplakia, malignant transformation rate was 
11% (vs. 40.8% in our study). Female patients 
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with leukoplakia lesions were more prevalent and 
higher rates of malignant transformation were 
seen in females, however, this difference was not 
statistically significant (P=0.609). This was similar 
to our findings, although we found the difference 
between the sex groups to be significant regard-
ing malignant transformation. Moreover, the ton-
gue was found to be the most common site for 
malignant change, however unlike our study they 
did not document a significant relation between 
location of lesion and malignant transformation 
(P=0.144). These statistically insignificant find-
ings may be attributed to their relatively low 
population size, which may not have been able to 
show a meaningful difference between the com-
parison groups. 
Malignant changes in non-homogenous lesions 
was 7 times higher compared to homogenous 
lesions (OR=7), which was similar to our result 
regarding the higher risk of malignant changes in 
erythroleukoplakia (type 2) compared to homo-
genous lesions (type 1) (OR= 6.26; 95% CI: 
3.164 - 12.38) (12). 
In a large retrospective study in Croatia (2), simi-
lar to our results, females and smokers made up 
the majority of patient with leukoplakia (57% and 
47%, respectively), which was statistically signifi-
cant (P<0.001). The higher frequency of leukop-
lakia in the female sex may seem contradicting as 
males have higher rates of smoking compared to 
females (13). The reason for this may be due to 
multiple factors. First, in our study population, 
the self-reported smoking rate in Iranian women 
is less than the actual number of smokers (14), 
although minor, this may have affected the re-
sults. Second is the fact that females seek medical 
attention more frequently than males for lesions 
like leukoplakia, which increased their number 
compared to males. 
In the same study (2), their malignant transforma-
tion rate was extremely lower than that docu-
mented in our study (0.64% vs. 40.8%), however 
majority of their patients had homogenous 
lesions, unlike our patients who had non-
homogenous lesions, furthermore our study had 
a much longer follow-up period. 
Our findings suggested that flat and white patch 
or plaques with red components were mostly as-
sociated with malignant change. This was also 
reported earlier where erythroleukoplakia had the 
highest chances for malignant transformation 
(15). Almost every study up to this date has 
found that a non-homogenous morphology for 
leukoplakia is associated with carcinomatous 
change (15). We found that as lesions change 
from a flat and homogenous structure to a more 
erythematous and complex structure, it is more 
likely to undergo malignant changes. In one 
study, the risk of malignancy in 
erythroleukoplakia was 4 times higher than that 
of a homogenous leukoplakia and among those 
that underwent malignant changes, 84% had red 
structures (9). 
Malignant changes were evaluated among pa-
tients with proliferative verrucous leukoplakia, 
which is an aggressive form of leukoplakia. In 
this study, cancer developed more frequently in 
non-smokers and females (up to four times) (16). 
Non-smokers also had higher prevalence of ver-
rucous leukoplakia; this supports our findings 
that non-smokers acquire more aggressive forms 
of leukoplakia. Patients also had a mean age of 
61.7 yr old showing that older patients acquire 
more severe forms of leukoplakia. The most 
common locations for this type of lesion were in 
the gingiva and on the tongue, respectively. In 
another study similar to the later study (17), only 
age and site of verrucous leukoplakia contribute 
to malignant changes in these types of lesions. 
The tongue and buccal mucosa were the most 
common sites for verrucous leukoplakia.  
The reason for our high rates of malignant 
changes when compared to studies from other 
countries, could be related to cultural differences, 
for example, many of Iranians who have leukop-
lakia lesions only refer for medical evaluation 
when the lesion has advanced, consequently 
showing high rates of malignant changes in biop-
sy reports. Another factor is that our study was 
conducted in two referral hospitals (for southern 
and central Iran) where most patients who are 
referred are medically complicated.  
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Our results showed a significant difference in 
malignant transformation rates between patient 
bellow 50 yr old and those over 50 yr old. These 
findings were also supported earlier (15). This 
finding might be because older patients may have 
had the leukoplakia for a longer amount of time, 
giving the lesion time to undergo malignant 
transformation.  
Data on the prevalence of malignant lesions and 
malignant changes in the two sexes have been 
somewhat contradicting in previous literature. 
Female patients have had higher rates of malig-
nant changes in some reports (18, 19), while oth-
ers have shown that these changes are more pre-
valent in males (20).  
We found a higher prevalence of leukoplakia 
among smokers. However, lower rates of malig-
nant changes were found in smokers. One expla-
nation for these phenomena might be that in 
smokers, tobacco is the cause of leukoplakia 
meanwhile in non-smokers other more danger-
ous carcinogenic factors might be the cause of 
leukoplakia, thus having higher chances of malig-
nant changes. 
 The site of malignant change is probably related 
to the habits of the patients (21), for example, 
patients who chew tobacco are prone to acquir-
ing malignant transformation in the buccal area 
and lips. The most common site for malignant 
changes in smokers was on the base of the 
mouth, while in non-smokers was on the side of 
the tongue (22). Majority of the women in our 
study were non-smokers; furthermore, they con-
stituted the majority of our patients with malig-
nant changes. This could have been the cause for 
the tongue as to being the most common site for 
malignancy. Overall, the different results among 
studies are due to different follow-up periods, 
different settings of study and the treatment that 
each patient received. 
Our study had some limitations. It was not feasi-
ble for us to consider genetic variation among 
patients as one study indicated that this could 
have affected malignant transformation (23). The 
retrospective nature of our study did not allow us 
to document a causality relationship between ma-
lignant change and different factors; furthermore, 
it did not allow us to have a single observer for 
defining the clinical morphology of the lesions, 
which may have affected the classification of 
some lesions. 
This is the first study to evaluate common and 
region-specific risk factors for malignant changes 
of leukoplakia in the Iranian population with an 
appropriate sample size. We also had one of the 
longest follow-ups among all the studies that 
have considered malignant changes in leukopla-
kia. Cohort studies with long follow-ups are 
needed to better clarify the causes and risk fac-
tors of malignant transformation in patients with 
leukoplakia. 
 
Conclusion 
 
A follow-up program and further work up should 
be considered for Iranian patients who have leu-
koplakia lesions that are flat and are white patch 
or plaques with red components, and for patients 
who have lesions located on the tongue and for 
nonsmokers who develops leukoplakia lesions. 
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